...
首页> 外文期刊>Journal of pharmaceutical sciences. >An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres.
【24h】

An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres.

机译:喷雾冷却的凝胶状50/13微球中水溶性差的药物的溶出速率提高机理的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The production and physicochemical characterisation of spray chilled Gelucire 50/13 microspheres is described with a view to improving the dissolution of a poorly water-soluble drug, piroxicam, and understanding the fundamental mechanisms associated with the improved drug release. Thermorheological testing was developed as a fast screening method for predicting the processability of dispersions for spray chilling preparation. Spray chilled piroxicam loaded microspheres were spherical in shape with a median diameter of circa 150 microm. DSC indicated no interaction between piroxicam and lipid matrix, while HSM studies performed in polarized light mode indicated that the spheres contained distinct drug crystals. Polarising light microscopy and small-angle XRD investigations on the hydration behaviour of the lipid and the spray chilled microspheres revealed the formation of liquid crystalline phases depending on the degree of hydration. The dissolution behaviour of the piroxicam loaded microspheres showed significant improvements compared to drug alone. The particle size, drug loading and aging of the microspheres were all found to have an influence on the release behaviour. It was proposed that Gelucire 50/13 microspheres release the entrapped piroxicam via formation of a lyotropic liquid crystalline phase, which allows dissolution of the drug particles in a finely divided, high surface area and well-wetted state.
机译:描述了喷雾冷却的Gelucire 50/13微球的生产和理化特性,目的是改善水溶性差的药物吡罗昔康的溶出度,并了解与改善的药物释放相关的基本机理。开发了热流变测试作为一种快速筛选方法,用于预测用于喷雾冷却制备的分散体的可加工性。装有喷雾冷却的吡罗昔康的微球为球形,中值直径约为150微米。 DSC表明吡罗昔康与脂质基质之间没有相互作用,而在偏振光模式下进行的HSM研究表明该球体包含不同的药物晶体。关于脂质和喷雾冷却的微球的水合行为的偏光显微镜和小角度XRD研究表明,液晶相的形成取决于水合程度。与单独使用药物相比,吡罗昔康装载的微球的溶解行为显示出显着改善。发现微球的粒径,载药量和老化都对释放行为有影响。有人提出Gelucire 50/13微球通过形成溶致液晶相来释放被截留的吡罗昔康,这使药物颗粒以细分的高表面积和良好润湿的状态溶解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号